Lumeng J Yu, Lorenzo Anez-Bustillos, Paul D Mitchell, Victoria H Ko, Jordan D Secor, Alexis Potemkin Hurley, Duy T Dao, Scott C Fligor, Bennet S Cho, Savas T Tsikis, Kathleen M Gura, Mark Puder
BACKGROUND: Intestinal failure-associated liver disease (IFALD), initially manifesting as cholestasis, is a complication in neonates on parenteral nutrition (PN). Soybean oil lipid emulsion (SOLE), though implicated in IFALD, was the only Food and Drug Administration (FDA)-approved initial intravenous lipid emulsion (ILE) for infants and children in the United States. A mixed-oil lipid emulsion (MOLE) gained popularity in patients at risk for IFALD, and was recently FDA-approved as an initial ILE in children...
October 29, 2022: JPEN. Journal of Parenteral and Enteral Nutrition